Welcome to the e-CCO Library!

Y-ECCO Literature Review: Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with Inflammatory Bowel Disease
Source: ECCO News Issue 03/2013
Authors: Erik Mooiweer
Y-ECCO Literature Review: Risk of melanoma and nonmelanoma skin cancer among patients with Inflammatory Bowel Disease
Source: ECCO News Issue 03/2012
Authors: Dobriana Panova
Y-ECCO Literature Review: Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn’s Disease
Source: ECCO News Issue 01/2013
Authors: Elisabeth Lippert
Y-ECCO Literature Review: Subcutaneus Golimumab Maintains Clinical Response in Patients with Moderate-To-Severe Ulcerative Colitis
Source: ECCO News Issue 04/2013
Authors: Valentina Petito
Y-ECCO Literature Review: Switch to adalimumab in patients with Crohn’s disease controlled by maintenance infliximab: prospective randomised SWITCH trial
Source: ECCO News Issue 03/2012
Y-ECCO Literature Review: Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease
Source: ECCO News Issue 04/2015
Authors: Barry Hall
Y-ECCO Literature Review: The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in Inflammatory Bowel Disease: The ATLAS study
Source: ECCO News Issue 01/2015
Authors: Philip Hendy
Y-ECCO Literature Review: The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric infl ammatory bowel disease
Source: ECCO News Issue 02/2012
Authors: Els Van de Vijver
Y-ECCO Literature Review: The safety of vedolizumab for Ulcerative Colitis and Crohn’s Disease
Source: ECCO News Issue 02/2016
Authors: João Sabino
Y-ECCO Literature Review: Tofacitinib, an oral Janus kinases inhibitor, in active Ulcerative Colitis
Source: ECCO News Issue 04/2012
Authors: Gionata Fiorino
Y-ECCO Literature Review: Tofacitinib, an oral Janus kinases inhibitor, in active Ulcerative Colitis
Source: ECCO News Issue 04/2012
Authors: Razvan Zaro
Y-ECCO Literature Review: Ustekinumab induction and maintenance therapy in refractory Crohn’s Disease
Source: ECCO News Issue 01/2013
Authors: Hans Peter Gröchenig
Y-ECCO Literature Review: Validation of Endoscopic Activity Scores in Patients With Crohn’s Disease Based on a Post Hoc Analysis of Data From SONIC.
Source: ECCO News Issue 04/2013
Authors: Clifford Kiat
Y-ECCO Literature Review: Validation of the Capsule Endoscopy Crohn’s Disease Activity Index (CECDAI or Niv score): a multicenter prospective study
Source: ECCO News Issue 02/2012
Authors: Bruno Rosa
Y-ECCO Literature Review: Vedolizumab as induction and maintenance therapy for Crohn’s Disease
Source: ECCO News Issue 01/2014
Authors: Marta Valente Pinto
Y-ECCO Literature Review: Vedolizumab as induction and maintenance therapy for Ulcerative Colitis
Source: ECCO News Issue 01/2014
Authors: Thomas Billiet
Y-ECCO Literature Review: Visceral adipocytes: old actors in obesity and new protagonists in Crohn’s Disease?
Source: ECCO News Issue 03/2012
Authors: Klára Frivolt